Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 152

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 152
---
 the SEC on October 10, 2023

4.11
 
Form of Convertible Note
 
Incorporated herein by reference to Exhibit 99.2 to the Company’s Form 8-K filed with the SEC on July 9, 2024

66

    10.1
     
    2019
    Equity Incentive Plan
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on February 10, 2020.

    10.2
     
    2023
    Equity Incentive Plan
     
    Incorporated
    herein by reference to Exhibit 10.12 to the Company’s Form 10-K/A filed with the SEC on October 30, 2023

    10.3
     
    Statement
    of Work and License Agreement by and among G-Tech Bio, LLC, the Company and G Health Research Foundation
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on February 3, 2020.

    10.4
     
    Note
    Purchase Agreement
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed with the SEC on March 31, 2020.

    10.5
     
    General
    Office Lease by and between the Registrant and Century City Medical Plaza Land Co., Inc. dated June 19, 2018
     
    Incorporated
    herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on June 25, 2018.

    10.6
     
    Employment
    Agreement, dated August 11, 2021, by and between the Company and Dr. Mark Dybul
     
    Incorporated
    herein by reference to Exhibit to 10.1 the Company’s Current Report on Form 8-K/A, filed with the SEC on August 16, 2021.

    10.7
     
    Amendment
    to Employment Agreement between Mark Dybul, M.D. and the Company, dated December 12, 2022
     
    Incorporated
    herein by reference to Exhibit to 10.1 the Company’s Current Report on Form